196 related articles for article (PubMed ID: 15703932)
1. 99mTc-sestamibi thyroid uptake in euthyroid individuals and in patients with autoimmune thyroid disease.
Santos AO; Zantut-Wittmann DE; Nogueira RO; Etchebehere EC; Lima MC; Tambascia MA; Camargo EE; Ramos CD
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):702-7. PubMed ID: 15703932
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
Oki GC; Zantut-Wittmann DE; de Oliveira Santos A; Guariento MH; Tambascia MA; de Almeida EA; Amorim BJ; Lima MC; Etchebehere EC; Camargo EE; Ramos CD
Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407
[TBL] [Abstract][Full Text] [Related]
3. Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease.
Sekulić V; Rajić M; Vlajković M; Ilić S; Bogićević M; Antić S; Dimić D
Hell J Nucl Med; 2006; 9(3):173-6. PubMed ID: 17160158
[TBL] [Abstract][Full Text] [Related]
4. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
Giordano A; Meduri G; Marozzi P; Rubini G; Burroni L; Cappagli M
Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474
[TBL] [Abstract][Full Text] [Related]
5. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m pertechnetate trapping and thyroid function in Hashimoto's thyroiditis.
Wang PW; Chen HY; Li CH; Liu RT; Chien WY; Tung SC
Clin Nucl Med; 1994 Mar; 19(3):177-80. PubMed ID: 8033462
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99 m sestamibi imaging in patients with subacute thyroiditis.
Hiromatsu Y; Ishibashi M; Nishida H; Kawamura S; Kaku H; Baba K; Kaida H; Miyake I
Endocr J; 2003 Jun; 50(3):239-44. PubMed ID: 12940451
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
9. Cutoff value of thyroid uptake of (99m)Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study.
Uchida T; Suzuki R; Kasai T; Onose H; Komiya K; Goto H; Takeno K; Ishii S; Sato J; Honda A; Kawano Y; Himuro M; Yamada E; Yamada T; Watada H
Endocr J; 2016; 63(2):143-9. PubMed ID: 26581846
[TBL] [Abstract][Full Text] [Related]
10. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
[TBL] [Abstract][Full Text] [Related]
11. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-sestamibi radio-guided surgery of loco-regional 131Iodine-negative recurrent thyroid cancer.
Rubello D; Salvatori M; Casara D; Piotto A; Toniato A; Gross MD; Al-Nahhas A; Muzzio PC; Pelizzo MR
Eur J Surg Oncol; 2007 Sep; 33(7):902-6. PubMed ID: 17267163
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.
Liu Z; Okada DR; Johnson G; Hocherman SD; Beju D; Okada RD
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):570-8. PubMed ID: 17952434
[TBL] [Abstract][Full Text] [Related]
14. Thyroid remnant estimation by Tc-99m-sestamibi scanning predicts the effectiveness of rhTSH-stimulated I-131 ablation in patients with differentiated thyroid carcinoma.
Giovanella L; Suriano S; Castellani M; Ceriani L; Verburg FA
Clin Nucl Med; 2011 Sep; 36(9):781-5. PubMed ID: 21825849
[TBL] [Abstract][Full Text] [Related]
15. Objective evidence of decreased salivary function in patients with autoimmune thyroiditis (chronic thyroiditis, Hashimoto's thyroiditis).
Changlai SP; Chen WK; Chung C; Chiou SM
Nucl Med Commun; 2002 Oct; 23(10):1029-33. PubMed ID: 12352603
[TBL] [Abstract][Full Text] [Related]
16. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
[TBL] [Abstract][Full Text] [Related]
17. The Diagnostic Utility of Color Doppler Ultrasonography, Tc-99m Pertechnetate Uptake, and TSH-Receptor Antibody for Differential Diagnosis of Graves' Disease and Silent Thyroiditis: A Comparative Study.
Zuhur SS; Ozel A; Kuzu I; Erol RS; Ozcan ND; Basat O; Yenici FU; Altuntas Y
Endocr Pract; 2014 Apr; 20(4):310-9. PubMed ID: 24246346
[TBL] [Abstract][Full Text] [Related]
18. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
[TBL] [Abstract][Full Text] [Related]
19. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.
Mariani G; Filocamo M; Giona F; Villa G; Amendola A; Erba P; Buffoni F; Copello F; Pierini A; Minichilli F; Gatti R; Brady RO
J Nucl Med; 2003 Aug; 44(8):1253-62. PubMed ID: 12902415
[TBL] [Abstract][Full Text] [Related]
20.
Zhao L; Zhang W; Xin Y; Wen Q; Bail L; Guan F; Bin J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):349-353. PubMed ID: 30413358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
